
Axitinib
–
Axitinib is primarily employed in the treatment of advanced renal cell carcinoma (kidney cancer). Acting as a tyrosine kinase inhibitor, Axitinib impedes the growth of cancer cells by thwarting the blood vessels' formation that nourishes the tumors.
Category: Kidney Cancer
Medically Reviewed by – Dr. Derek Lawson, MD
Last Updated on 9 April 2026

